Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,657 | -33,648 | -90 | -14,087 | -38,627 |
| Depreciation Amortization | 4,300 | 3,557 | 2,206 | 2,375 | 2,129 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -35 |
| Accounts receivable | -6,813 | 1,023 | -1,722 | -11,649 | -9,320 |
| Accounts payable and accrued liabilities | 9,531 | 14,309 | -1,279 | 11,653 | 617 |
| Other Working Capital | -5,090 | 10,294 | -8,308 | -1,330 | -5,543 |
| Other Operating Activity | -4,797 | -4,021 | 5,141 | 678 | 12,303 |
| Operating Cash Flow | $-23,526 | $-8,486 | $-4,052 | $-12,360 | $-38,476 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -214 | -36 | -8 | -46 |
| Investing Cash Flow | $N/A | $-214 | $-36 | $-8 | $-46 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,815 | 591 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | -148 |
| Debt Repayment | N/A | N/A | -147 | -67 | N/A |
| Common Stock Issued | 13,671 | 4,055 | 419 | 14,415 | 27,762 |
| Financing Cash Flow | $19,486 | $4,646 | $272 | $14,348 | $27,614 |
| Beginning Cash Position | 5,343 | 9,397 | 13,213 | 11,233 | 22,141 |
| End Cash Position | 1,303 | 5,343 | 9,397 | 13,213 | 11,233 |
| Net Cash Flow | $-4,040 | $-4,054 | $-3,816 | $1,980 | $-10,908 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,526 | -8,486 | -4,052 | -12,360 | -38,476 |
| Capital Expenditure | N/A | -214 | -36 | -8 | -46 |
| Free Cash Flow | -23,526 | -8,700 | -4,088 | -12,368 | -38,522 |